These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Peptide Multifunctionalized Gold Nanorods with Dual pH/NIR Responsive Release of Doxorubicin for High-Efficiency Cancer Treatment.
    Author: Wang J, Ma K, Wang H, Hu Z, Fu Y, Li F.
    Journal: J Biomed Nanotechnol; 2019 Nov 01; 15(11):2164-2178. PubMed ID: 31847931.
    Abstract:
    In this study, gold nanorods (GNRs), uniformly coated with polydopamine (PDA), were developed as a multifunctional nanocarrier for targeted, pH, and near infrared (NIR) irradiation dual-stimuli triggered drug delivery. Doxorubicin (DOX), a hydrophobic chemotherapeutic drug, was conveniently and heavily loaded into the nanocarrier through π-π stacking and hydrogen bonding interactions. It was further passivated by thiolated poly(ethylene glycol)-tumor homing peptides (NGR and TAT) to improve its cancer tissue penetrating, and accurate targeting ability. The developed NGR/TAT-DOX-PDA@GNRs could not only specifically and effectively deliver therapeutic agents to the tumor sites, but also facilitated controlled release of DOX, triggered via pH and near infrared light dual-stimuli. The studies of tumor cell ablation confirmed that this chemo-photothermal synergistic therapy offered superior therapeutic efficacy, improved chemosensitivity, and enhanced chemotherapeutic efficacy. Therefore, this combination of photothermal therapy and chemotherapy, based on NGR/TAT-DOX-PDA@GNRs, can maximize the therapeutic efficacy, and minimize the dosage-related adverse effects in cancer treatment.
    [Abstract] [Full Text] [Related] [New Search]